Literature DB >> 8757836

Counterprotective effect of erythrocytes in experimental bacterial peritonitis is due to scavenging of nitric oxide and reactive oxygen intermediates.

Y M Kim1, S J Hong, T R Billiar, R L Simmons.   

Abstract

Erythrocytes (RBC) in the peritoneal cavity significantly increase the lethality of bacterial peritonitis. The lethality is known to be associated with, and perhaps due to, increased bacterial counts in the peritoneal cavity. The mechanism is unknown. In this study, we investigated the hypothesis that RBC scavenge reactive oxygen intermediates (ROI) and nitric oxide (NO), so that the counterprotective effect is due to a loss of the microbiostatic activity of both ROI and NO. To study this effect, rats were subjected to a peritoneal inoculation of live Escherichia coli without RBC (nonlethal dose) or with RBC (lethal dose). The adjuvant effect of RBC was not modified by NG-monomethyl-L-arginine (NMA, an NO synthase inhibitor), superoxide dismutase, catalase, mannitol, or a combination of these agents. Furthermore, the increased number of bacteria in the peritoneal cavity in the presence of RBC was unaffected by these treatments. The administration of NMA with bacteria alone (no RBC) converted a nonlethal model into a lethal one associated with higher intraperitoneal bacterial counts. A similar effect was seen with superoxide dismutase and catalase but not with mannitol. During bacterial peritonitis in the absence of RBC, superoxide and NO formation (determined by the total nitrite plus nitrate formed) was detected in the ascites and inducible NO synthase mRNA expression was present in the peritoneal cells. In the absence of RBC, superoxide was detected and oxidation of dihydrorhodamine to rhodamine was observed, indicating that peroxynitrite was produced. Both were blocked by the inclusion of RBC. Preinjection with a low inoculum of killed bacteria protected the rats from a subsequent lethal peritoneal bacterial challenge; this effect was reversed by scavenging ROI and NO. The protective effect of killed bacterial pretreatment was lost when RBC were placed in the peritoneal cavity. In vitro bactericidal activity of NO- and ROI-generating macrophages was also inhibited by RBC or by inhibiting ROI and NO formation. Taken together, these data are consistent with the hypothesis that RBC can impair bacterial clearance by removing both NO and ROI, suggesting that NO in combination with superoxide may be important to the antimicrobial defenses of the peritoneal cavity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757836      PMCID: PMC174190          DOI: 10.1128/iai.64.8.3074-3080.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  A TOXIC FACTOR IN ABDOMINAL INJURY. II. THE ROLE OF THE RED CELL COMPONENT.

Authors:  J H DAVIS; A B YULL
Journal:  J Trauma       Date:  1964-01

2.  The reaction of no with superoxide.

Authors:  R E Huie; S Padmaja
Journal:  Free Radic Res Commun       Date:  1993

3.  Erythrocyte catalase. A somatic oxidant defense?

Authors:  N S Agar; S M Sadrzadeh; P E Hallaway; J W Eaton
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

4.  DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.

Authors:  D A Wink; K S Kasprzak; C M Maragos; R K Elespuru; M Misra; T M Dunams; T A Cebula; W H Koch; A W Andrews; J S Allen
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

5.  Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells.

Authors:  J A Royall; H Ischiropoulos
Journal:  Arch Biochem Biophys       Date:  1993-05       Impact factor: 4.013

6.  The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli.

Authors:  L Brunelli; J P Crow; J S Beckman
Journal:  Arch Biochem Biophys       Date:  1995-01-10       Impact factor: 4.013

7.  Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury.

Authors:  I Y Haddad; G Pataki; P Hu; C Galliani; J S Beckman; S Matalon
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.

Authors:  K Matsumoto; T Otani; T Une; Y Osada; H Ogawa; I Azuma
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide.

Authors:  R B Lorsbach; W J Murphy; C J Lowenstein; S H Snyder; S W Russell
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase.

Authors:  H Ischiropoulos; L Zhu; J Chen; M Tsai; J C Martin; C D Smith; J S Beckman
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

View more
  4 in total

1.  Inhibition of protein synthesis by nitric oxide correlates with cytostatic activity: nitric oxide induces phosphorylation of initiation factor eIF-2 alpha.

Authors:  Y M Kim; K Son; S J Hong; A Green; J J Chen; E Tzeng; C Hierholzer; T R Billiar
Journal:  Mol Med       Date:  1998-03       Impact factor: 6.354

2.  Hemoglobin toxicity in experimental bacterial peritonitis is due to production of reactive oxygen species.

Authors:  Y M Yoo; K M Kim; S S Kim; J A Han; H Z Lea; Y M Kim
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats.

Authors:  Yan Li; Xuemei Li; Michael Haley; Yvonne Fitz; Eric Gerstenberger; Steven M Banks; Peter Q Eichacker; Xizhong Cui
Journal:  Intensive Care Med       Date:  2006-06-15       Impact factor: 17.440

Review 4.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.